Fortis Healthcare Limited (BOM:532843)
India · Delayed Price · Currency is INR 962.95
+4.15 (0.43%)
At close: Jun 19, 2026
Fortis Healthcare Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Fortis Healthcare stock has a consensus rating of "Strong Buy" and an average price target of ₹1,105. The average 1-year stock price forecast is 14.74% higher than the current stock price, while the lowest is ₹950.00 (-1.34%) and the highest is ₹1,192 (+23.79%).
Price Target: ₹1,105 (+14.74%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Fortis Healthcare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 12 | 12 | 13 | 12 | 13 |
| Buy | 3 | 2 | 2 | 2 | 3 | 3 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 18 | 18 | 19 |
Financial Forecast
Revenue This Year
106.45B
from 91.28B
Increased by 16.62%
Revenue Next Year
122.26B
from 106.45B
Increased by 14.86%
EPS This Year
18.20
from 14.03
Increased by 29.72%
EPS Next Year
23.38
from 18.20
Increased by 28.47%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 109.9B | ||
| Avg | 106.4B | ||
| Low | 103.7B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 20.4% | ||
| Avg | 16.6% | ||
| Low | 13.7% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 19.80 | ||
| Avg | 18.20 | ||
| Low | 16.60 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 41.1% | ||
| Avg | 29.7% | ||
| Low | 18.3% |